Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liposomal Bupivacaine in Implant Based Breast Reconstruction

NCT02659501 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT02659501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02659501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liposomal Bupivacaine in Implant Based Breast Reconstruction
Lead sponsor
Loma Linda University
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2015
Completion date
July 31, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, postoperative pain